Histone modifications and cancer: biomarkers of prognosis?
- PMID: 22957310
- PMCID: PMC3433108
Histone modifications and cancer: biomarkers of prognosis?
Abstract
Epigenetic dysregulation is being increasingly recognized as a hallmark of cancer. Post-translational modifications of histones, in particular, are known to play important roles gene expression alterations in cancer development and progression. Given their key involvement in the various stages of carcinogenesis, histone modifications are also being explored as potential biomarkers of disease progression and prognosis. This review will therefore discuss the role of histone modifications in cancer biology and will explore their prognostic potential.
Keywords: Histone modifications; biomarkers; cancer; prognosis.
References
-
- Iacobuzio-Donahue CA. Epigenetic changes in cancer. Annu Rev Pathol. 2009;4:229–249. - PubMed
-
- Waddington CH. Strategy of the Genes. London: Geo Allen & Unwin; 1957.
-
- Kurdistani SK. Histone modifications in cancer biology and prognosis. Prog Drug Res. 2011;67:91–106. - PubMed
-
- Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3:415–428. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources